Rivaroxaban plasma levels in patients admitted for bleeding events: insights from a prospective study

BACKGROUND: Serious bleeding events have been frequently described in patients taking direct oral anticoagulants (DOAC). In secondary analyses of phase 3 trials, DOAC plasma concentrations were shown to correlate with bleeding outcomes. This study aimed to describe rivaroxaban plasma levels in patie...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Thromb J
Main Authors: Sennesael, Anne-Laure, Larock, Anne-Sophie, Douxfils, Jonathan, Elens, Laure, Stillemans, Gabriel, Wiesen, Martin, Taubert, Max, Dogné, Jean-Michel, Spinewine, Anne, Mullier, François
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2018
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6231259/
https://ncbi.nlm.nih.gov/pubmed/30455596
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12959-018-0183-3
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados